Drug details
Adynovate (antihemophilic factor (recombinant), pegylated for injection)
type of Hemostatics, Coagulation Factors
Adynovate [antihemophilic factor (recombinant), PEGylated] is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older) with hemophilia A (congenital factor VIII deficiency) for on-demand treatment and control of bleeding episodes and routine prophylaxis to reduce the frequency of bleeding episodes. Adynovate is not indicated for the treatment of von Willebrand disease.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- itching,
- rash,
- fever,
- pale skin,
- lightheadedness,
- fast heartbeats,
- numbness,
- tingling,
- dizziness,
- wheezing,
- fainting,
- chest tightness,
- cold sweat,
- increased bleeding episodes,
- any bleeding that will not stop, and
- chest pain
The following drugs are related to Adynovate, either as a replacement or used together:
- Advate ([antihemophilic factor (recombinant), plasma/albumin-free method] for intravenous injection)
- Alphanate (antihemophilic factor)
- Altuviiio (antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl)
- Xyntha (antihemophilic factor)
- Helixate FS (antihemophilic factor (recombinant))
- Kogenate FS (antihemophilic factor (recombinant))
- Kovaltry (antihemophilic factor (recombinant) for intravenous administration)
- Novoeight (antihemophilic factor (recombinant) lyophilized powder for intravenous injection)
- Eloctate (antihemophilic factor (recombinant), fc fusion protein for intravenous infusion)
- Jivi (antihemophilic factor (recombinant), pegylated-aucl for injection)
- Humate-P (antihemophilic factor/von willebrand factor complex (human) injection)
- Novoseven (coagulation factor viia (recombinant))
- Sevenfact (coagulation factor viia (recombinant)-jncw for injection)
- Corifact (factor xiii concentrate (human) lyophilized powder reconstitution for intravenous use)
- Cyklokapron (tranexamic acid)
- DDAVP (desmopressin acetate tablets)
- DDAVP Injection (desmopressin acetate injection)
- DDAVP Nasal Spray (desmopressin acetate nasal spray)
- DDAVP Rhinal Tube (desmopressin acetate rhinal tube)
- Esperoct ([antihemophilic factor (recombinant), glycopegylated-exei] injection)
- Hemgenix (etranacogene dezaparvovec-drlb suspension for iv infusion)
- Profilnine (factor ix complex intravenous administration)
- Roctavian (valoctocogene roxaparvovec-rvox suspension)